Screener
Rallybio Corporation RLYB Q4 2025 Annual earnings
Reported March 12, 2026 · Before market open
Revenue$222.0KBeat by $122.0K
EPS-$1.28Miss by $0.04
Revenue estimate$100.0K
EPS estimate-$1.24
Next report
Nov 5, 2026 (in 2 months)EPS estimate-$1.44
Versus estimates
Revenue
Q1 2026$212.0KIn line
Q4 2025$222.0KBeat by $122.0K
Q3 2025$212.0KBeat by $145.3KQ2 2025$212.0KBeat by $145.3KQ1 2025$212.0KDiluted EPS
FAQ
- When did Rallybio Corporation report Q4 2025 earnings?
- Rallybio Corporation (RLYB) reported Q4 2025 earnings on March 12, 2026 before market open.
- What were Rallybio Corporation's Q4 2025 revenue and EPS?
- Rallybio Corporation reported revenue of $222.0K and eps of $-1.28 for Q4 2025.
- Did Rallybio Corporation beat estimates in Q4 2025?
- Revenue beat the consensus estimate of $100.0K by $122.0K. EPS missed the consensus estimate of $-1.24 by $0.04.
- How did Rallybio Corporation's Q4 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 484.2% from $38.0K a year earlier and eps declined 412.0% from $-0.25.
- Where can I find Rallybio Corporation's Q4 2025 SEC filings?
- You can read the 10-K periodic report (0001628280-26-018261) directly on SEC EDGAR. The filing index links above go to sec.gov.
